Evidence map›Paper›PMID 24436077›Full record

ArticleJournal of biomolecular screening2014

Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells.

Simon J Gruber, Razvan L Cornea, Ji Li, Kurt C Peterson, Tory M Schaaf, Gregory D Gillispie, Russell Dahl, Krisztina M Zsebo, Seth L Robia, David D Thomas

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomolecular screening, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Development of activators for SERCA2a for heart failure treatments.European journal of medicinal chemistry · 2026
    Article
  5. Sarco/Endoplasmic Reticulum CaJournal of the American Heart Association · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Ubiquitination detection techniques.Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Simon J Gruber1Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Razvan L Cornea
Ji Li
Kurt C Peterson
Tory M Schaaf
Gregory D Gillispie
Russell Dahl
Krisztina M Zsebo
Seth L Robia
David D Thomas
University of Minnesota · USCelladon Corporation (United States) · USFluorescence Innovations (United States) · USLoyola University Chicago · USRosalind Franklin University of Medicine and Science · US

Funding

TRAINING PROGRAM IN MUSCLE RESEARCHT32AR007612 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JAMES M ERVASTI, DAWN A LOWE · 2001 to 2026
$11.3M
Pathophysiological Regulation of Cardiac Myocyte RyR ChannelR01HL092097 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, Robyn T Rebbeck · 2010 to 2026
$9.3M
Structural Determinants of Calcium Pump RegulationR01HL092321 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI Seth L Robia · 2008 to 2026
$8.9M
Structural Dynamics of Muscle Calcium ATPase RegulationR01GM027906 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI THOMAS, DAVID D · 1985 to 2016
$8.6M
Use of specific transcription factors to promote limb regeneration capacityP30AR057220 · NIAMS · UNIVERSITY OF MINNESOTA · PI ERVASTI, JAMES M · 2009 to 2013
$3.0M
Structure Changes of Ion-motive ATPasesR01HL106189 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI ROBIA, SETH L · 2011 to 2014
$1.5M
High-throughput screen to discover SERCA activators for heart failure therapyR21AG042996 · NIA · UNIVERSITY OF MINNESOTA · PI THOMAS, DAVID D · 2012 to 2013
$408k
NHLBI NIH HHS HL92097NHLBI NIH HHS R01 HL092097NHLBI NIH HHS R01 HL092321NHLBI NIH HHS R01 HL106189NIAMS NIH HHS AR57220NIAMS NIH HHS P30 AR057220NIAMS NIH HHS T32 AR007612NIA NIH HHS AG42996NIA NIH HHS R21 AG042996NIGMS NIH HHS GM27906NIGMS NIH HHS R01 GM027906PHS HHS MDA218102
6 · The paper itself

Abstract

We have used a "two-color" SERCA (sarco/endoplasmic reticulum calcium ATPase) biosensor and a unique high-throughput fluorescence lifetime plate reader (FLT-PR) to develop a high-precision live-cell assay designed to screen for small molecules that perturb SERCA structure. A SERCA construct, in which red fluorescent protein (RFP) was fused to the N terminus and green fluorescent protein (GFP) to an interior loop, was stably expressed in an HEK cell line that grows in monolayer or suspension. Fluorescence resonance energy transfer (FRET) from GFP to RFP was measured in the FLT-PR, which increases precision 30-fold over intensity-based plate readers without sacrificing throughput. FRET was highly sensitive to known SERCA modulators. We screened a small chemical library and identified 10 compounds that significantly affected two-color SERCA FLT. Three of these compounds reproducibly lowered FRET and inhibited SERCA in a dose-dependent manner. This assay is ready for large-scale HTS campaigns and is adaptable to many other targets.

Indexed as

Fluorescence Resonance Energy TransferHigh-Throughput Screening AssaysAnimalsBiosensing TechniquesGreen Fluorescent ProteinsHEK293 CellsHepatocytesHumansLuminescent ProteinsRed Fluorescent ProteinSarcoplasmic Reticulum Calcium-Transporting ATPasesSmall Molecule LibrariesGreen Fluorescent ProteinsLuminescent ProteinsRed Fluorescent ProteinSarcoplasmic Reticulum Calcium-Transporting ATPasesSmall Molecule Librariesenzyme activationFRETHEKLOPACscreeningSERCA2a

Identifiers

PMID24436077
PMCPMC4013825
OpenAlexW2098505754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.